Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Exploring plasma microRNA profiling and signaling pathways in comorbidity-free sickle cell anemia: a pilot case-control study.
Journal: BMC research notes
Published: January 11, 2026
Disruption of a six-nucleotide miRNA motif improves PKD1 dosage and ameliorates polycystic kidney disease.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
Disruption of a six-nucleotide miRNA motif improves PKD1 dosage and ameliorates polycystic kidney disease.
Journal: Nucleic acids research
Published: October 23, 2025
KDOQI US Commentary on the KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: October 10, 2025
The nucleobase guanine at the 3'-terminus of oligonucleotide RGLS4326 drives off-target AMPAR inhibition and CNS toxicity.
Journal: Nature communications
Published: October 30, 2024
An RNA transmethylation pathway governs kidney nephrogenic potential.
Journal: Nature communications
Published: May 30, 2024
PKD1 and PKD2 mRNA cis-inhibition drives polycystic kidney disease progression.
Journal: Nature communications
Published: January 27, 2022
Enhancer and super-enhancer landscape in polycystic kidney disease.
Journal: Kidney international
Published: November 19, 2021
The role of PPARα in autosomal dominant polycystic kidney disease.
Journal: Current opinion in nephrology and hypertension
Published: May 20, 2020
Interstitial microRNA miR-214 attenuates inflammation and polycystic kidney disease progression.
Journal: JCI insight
Published: September 30, 2019
Manipulation of renal gene expression using oligonucleotides.
Journal: Methods in cell biology
Published: September 09, 2019
Last Updated: 09/26/2026